Neuroblastoma

Using advanced omics and computational techniques, the researchers found that both cancer and immune cells changed after treatment.

PEEL-224, a therapy to treat high-risk tumors, enters a pediatric clinical trial after a decade of groundbreaking research.

This week’s In The News highlights the legacy of Dr. Audrey Evans, newly elected AACR fellows, and a novel approach for rare disease.

As the pediatric cancer charity celebrates its 20th anniversary, Cornerstone is highlighting the groundbreaking research at CHOP fueled by two decades of collaboration.

CHOP researchers are looking to enhance the understanding of the possible genetic links between childhood cancers and structural birth defects.

Congratulations to physician scientist Dr. Yael Mosse, who received a Penn Medicine Award of Excellence for her contributions to pediatric oncology, and more.

Researchers identify cell surface protein DLK1 as a potential immunotherapeutic target for neuroblastoma.

Adam Wolpaw, MD, PhD, and Timothy Spear, MD, PhD, have been awarded grants from Hyundai Hope On Wheels to improve CAR T-cell therapy.

In The News this week, we celebrate CHOP being named a top children’s hospitals in the nation for the 17th consecutive year.